BCC Research
BCC Research
  1. Home
  2. Market Research Reports
  3. Pharmaceuticals
  4. PHM056A
Therapies for Depressive and Anxiety Disorders

Therapies for Depressive and Anxiety Disorders

Report Code: PHM056A

Publish Date: Feb 2010

Publisher: BCC Publishing

Category: Pharmaceuticals

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • The global market for therapies for depressive and anxiety disorders was $28 billion in 2008. It increased to $29.4 billion in 2009. This is projected to reach  $38.5 billion in 2014 at a compound annual growth rate (CAGR) of 5.6%
  • Sales in antidepressants products were nearly $15.4 billion in 2008. It increased to $16.2 billion in 2009. This market is projected to reach $21.2 billion in 2014, for a 5-year CAGR of 5.5%.
  • Sales in antianxiety drugs were nearly $12.6 billion in 2008. It increased to $13.2 billion in 2009. This market is projected to reach $17.3 billion in 2014, for a 5-year CAGR of 5.6%.

INTRODUCTION

STUDY GOALS AND OBJECTIVES 

The objectives of the study are to present a comprehensive look at disorders that affect the mind, specifically that cause depression and anxiety. An overall discussion of mental disorders associated with depression and anxiety is presented along with an in-depth discovery of the various diseases and disorders that present significant problems for individuals and society. Markets are divided according to drug type because several products are used in many different disorders. 

REASONS FOR STUDY
 
This BBC study is presented to highlight the exciting area of mental health, specifically relating to depression and anxiety. Because in-depth study of the workings of the brain is a fairly new area of intense study, there are new and changing theories. The discovery of new mechanisms and chemicals in the brain has provided additional avenues for research and development of products that may alter the course of the diseases or modify the outcome. This study analyzes the current therapies for depression and anxiety and explores the new therapies that are in the pipeline to treat depression and anxiety. The study also addresses the many and varied issues and trends affecting the market. Because of the rapidly evolving climate of psychological disorders and the increasing knowledge of the workings of the brain, manufacturers of therapies for depressive and anxiety disorders must remain ever vigilant of the changing environment and strive to keep abreast of current and potential opportunities.
 
SCOPE OF STUDY
 
The report is designed to be a comprehensive business tool to provide an in-depth look at therapies for depression and anxiety. The geographic scope of the report is global with an emphasis on the United States. The report identifies the different disorders that manifest with depressive and anxiety symptoms; gives an explanation of the disorders; cites incidence; identifies specific drug types; presents current treatments, market size, and market participants; and presents potential treatments in research and development.
 
The market for therapies for depressive and anxiety disorders is divided into two areas:
  • Therapies for depression
  • Therapies for anxiety.
All markets are further broken down into specific types of products that are discussed in detail, measuring current and potential market size; identifying current and potential market drivers; detailing from 2006, 2007, 2008, 2009, and 2014; assessing current and potential competitors; and identifying current competitor market shares.
 
METHODOLOGY AND INFORMATION SOURCES
 
The information and analysis presented in this BCC report are based on extensive first-hand interviews with primary executives, product managers, clinical specialists, and doctors involved in mental health and psychotherapeutics. Industry experts’ perspectives as well as company reports were used in the market analysis. Background information was obtained from various government, business, medical journal, and trade magazines. Key information from published literature was used to conduct interviews with more than 21 industry participants to validate and obtain expert opinions on current and future trends. Interviews were also used to confirm and/or adjust market size and market share estimates as well as formulating market projections. 
 
ANALYST CREDENTIALS
 
Mary Anne Crandall is a Medical Analyst specializing in the pharmaceutical industry for the last 18 years. She has completed several in-depth studies on various medical topics requiring both great medical expertise and excellent knowledge of the industry. Mary Anne has an M.S. in psychology and is pursuing a PhD in education.
 
BCC ONLINE SERVICES
 
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:  
  • Examine BCC’s complete catalog of Market Research Reports and place direct orders
  • Subscribe to any of BCC’s many industry newsletters
  • Read announcements of recently published reports and newly launched newsletters
  • Register for BCC’s well-known conferences
  • Request additional information on any BCC product
  • Take advantage of special offers 
DISCLAIMER
 
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or its use. 
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? Explore Offers
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
[+] Show Chapter Details
Title/Chapter NamePagesMember Price
Full Report: Therapies for Depressive and Anxiety Disorders161Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: EXECUTIVE SUMMARY2Free
Chapter- 3: INDUSTRY OVERVIEW88Free
Chapter- 4: MARKET SIZE AND GROWTH18Free
Chapter- 5: RESEARCH AND DEVELOPMENT8Free
Chapter- 6: COMPETITIVE ANALYSIS8Free
Chapter- 7: PATENT ANALYSIS1Free
Chapter- 8: C. CRAMER & CO. GMBH24Free
Chapter- 9: APPENDIX9Free

Related Reports

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 50

  • Summary Table: TOTAL MARKET FOR DEPRESSIVE AND ANXIETY DISORDERS, THROUGH 2014
  • Table 1: WORLD POPULATION BY SELECTED GEOGRAPHICAL REGION, 2008-2050
  • Table 2: ESTIMATED WORLD POPULATION BY AGE AND GEOGRAPHICAL REGION, 2008
  • Table 3: POPULATION OVER 65 BY YEAR AND REGION, 2008-2050
  • Table 4: BEST ESTIMATE 1-YEAR PREVALENCE RATES BASED ON ECA AND NCS, AGES 18-54
  • Table 5: PERCENTAGE OF INDIVIDUALS 12 YEARS AND OLDER WITH DEPRESSION BY DEMOGRAPHIC CHARACTERISTIC—AGE, SEX, AND RACE, U.S. 2006
  • Table 6: PERCENTAGE OF INDIVIDUALS WITH DEPRESSION BY AGE AND POVERTY STATUS, UNITED STATES 2006
  • Table 7: INDIVIDUALS 12 YEAR OF AGE AND OLDER REPORTING DIFFICULTY WITH THEIR WORK, HOME, AND SOCIAL ACTIVITIES BY SEX AND DEPRESSION SEVERITY, UNITED STATES, 2006
  • Table 8: INDIVIDUALS 12 YEARS OF AGE AND OLDER CONTACTING A MENTAL HEALTH PROFESSIONAL IN THE PAST 12 MONTHS, BY DEPRESSION SEVERITY, UNITED STATES 2006
  • Table 9: BEST ESTIMATE PREVALENCE RATES BASED ON EPIDEMIOLOGICAL CATCHMENT AREA, AGE 55+
  • Table 10: RISK FACTORS FOR MAJOR DEPRESSIVE AND BIPOLAR DISORDERS
Sample Report

Recent Reports

Therapies for Rheumatoid Arthritis: Technologies and Global Markets

Published - Jul 2025 | Publisher - BCC Publishing | Code - PHM072B

The global market for rheumatoid arthritis therapies was valued at $28.5 billion in 2024 and is estimated to increase from $30.2 billion in 2025 to reach $41.1 billion by 2030, at a compound annual growth rate (CAGR) of 6.3% from 2025 through 2030.

Anti-Parkinson's Drugs: Global Markets to 2030

Published - Jul 2025 | Publisher - BCC Publishing | Code - PHM193B

The global market for anti-Parkinson’s drugs is projected to grow from $6.1 billion in 2025 to reach $9.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2030.

Global Markets for Infectious Disease Treatments

Published - Jul 2025 | Publisher - BCC Publishing | Code - PHM061F

The global market for infectious disease treatments is expected to grow from $72.5 billion in 2025 and is projected to reach $101 billion by the end of 2030, at a compound annual growth rate (CAGR) of 6.9% during the forecast period of 2025 to 2030.

Disease-Modifying Therapies for Alzheimer’s Disease: Global Markets

Published - Jun 2025 | Publisher - BCC Publishing | Code - PHM283A

This report provides an overview of the global and regional markets for disease-modifying therapies for Alzheimer’s disease. It includes global revenue ($ million) for base year data of 2024, estimates for 2025, and CAGR forecasts through 2030.

Global Markets for Allergy Diagnostics and Treatments

Published - Jun 2025 | Publisher - BCC Publishing | Code - PHM026D

The global market for allergy diagnostics and treatment is projected to grow from $67.8 billion in 2025 to $96.4 billion by the end of 2030, at a compound annual rate growth (CAGR) of 7.3% from 2025 through 2030.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Therapies for Depressive and Anxiety Disorders
Customize This Report
Customize Report
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

Contact

© 2025 BCC Research

Privacy Policy |Site Map|Terms & Conditions